In multi-layer intravascular catheter shaft production, VESTAMID Care ML17 is processed as the outer jacket layer or as a structural layer in three-layer coextrusion, where the inner liner is HDPE or a soft polyurethane and the middle layer is selected for adhesion to both substrates. The resin is pre-dried in a desiccant dryer at 80 °C until residual moisture falls below 0.10 % by weight; this prevents hydrolytic chain scission when the melt is held at 220 °C to 240 °C. The jacket-to-tie-layer-to-liner weight ratio is maintained gravimetrically, with ML17 representing 30 % to 60 % of total wall weight depending on French size and burst pressure. The extrusion line is a triple-layer coextrusion system with 16 mm, 20 mm, and 16 mm screw diameters, each at L/D 24:1, followed by a gear pump and a multi-manifold spiral die. Temperature zones are set from 190 °C in the feed section to 235 °C at the die head. The ML17 jacket thickness is maintained between 0.05 mm and 0.20 mm for catheter sizes from 4 Fr to 10 Fr. Post-extrusion annealing at 90 °C for 4 h in circulating air stabilizes crystallinity and limits post-extrusion shrinkage to within ±0.03 mm of the target outer diameter when tooling compensation is applied. Biocompatibility evaluation follows ISO 10993-1:2018 for a surface-contacting, limited-duration device; the test panel includes ISO 10993-5:2009, ISO 10993-10:2010, and ISO 10993-4:2017 where blood contact is intended. Manufacturing is conducted under ISO 13485:2016 quality management systems. Terminal products are catheter shafts, introducer sheaths, and guide-catheter outer jackets.

Batch-to-batch variation in melt volume-flow rate should be monitored according to ISO 1133-1:2022 at 235 °C under 2.16 kg load; a deviation greater than 10 % from the qualification lot can shift outer diameter growth and jacket concentricity in the multi-manifold die. If regrind is used, the maximum regrind level is typically 20 % by weight and must be free of lint, plasticizer residues, or silicone oil; contamination can delaminate the jacket/tie-layer interface under burst pressure testing. Drying at a dew point below -30 °C is maintained to prevent moisture re-uptake before the extruder feed throat.

What Limits the Post-Sterilization Fit of Luer Connectors?

Injection-molded Luer lock hubs, stopcock bodies, and male/female adapters made from VESTAMID Care ML17 experience post-molding shrinkage and water absorption that influence engagement force, leak tightness, and dimensional conformance after sterilization. The resin is pre-dried to 0.10 % residual moisture, then processed at a melt temperature from 220 °C to 250 °C and a mold temperature from 60 °C to 80 °C. A reciprocating screw with L/D 20:1 and compression ratio 2.5:1 is used; back pressure is held at 50 bar to 100 bar, and injection speed is staged to prevent jetting in thin-wall gate areas as small as 0.5 mm. A 1 wt% to 2 wt% medical-grade masterbatch may be added for color, provided the masterbatch carries ISO 10993-5:2009 and USP <88> Class VI documentation. After ejection, components are annealed at 95 °C for 2 h in a circulating-air oven to reduce residual stress and stabilize the Luer taper diameter. Dimensional conformity is verified against ISO 80369-7:2016 and ISO 80369-20:2015; leakage testing is performed at 1250 mm Hg differential pressure. Gamma sterilization at 25 kGy to 40 kGy is applied to disposable connector assemblies; dimensional change after irradiation is documented in supplier technical literature as less than 0.2 %, but cavity-specific validation is required because thin-walled bosses can exhibit asymmetric shrinkage during post-irradiation storage. Terminal products are arterial line connectors, luer adapters, and three-way stopcocks.

Post-sterilization fit is also influenced by moisture absorption after autoclaving. If connector assemblies are steam sterilized at 121 °C for 30 min, PA12 absorbs water and the Luer taper can swell by 0.05 mm to 0.12 mm on the diameter, which must be accounted for in the mold steel dimension. This is a critical process conflict; over-drying below 0.05 % can embrittle thin features during ejection, while under-drying above 0.15 % can create splay and degrade molecular weight.

Surgical instrument handles and autoclavable forceps require a balance of stiffness, impact strength, and repeated steam sterilization tolerance. VESTAMID Care ML17 is molded at 230 °C to 250 °C with a mold temperature of 70 °C to 80 °C. For black instrument components, 2 wt% of a medical-grade carbon black masterbatch is pre-blended with the pellets; the masterbatch carrier and colorant must comply with ISO 10993-5:2009 and USP <88> Class VI. The material’s low water absorption compared with PA 6 and PA 66 reduces dimensional change during steam autoclave cycles at 121 °C. Repeated exposure to 134 °C steam for more than 100 cycles may initiate surface microcracking because of hydrolytic chain scission; therefore, each device geometry is validated under ISO 17665-1:2006 and ISO 10993-1:2018 before release. Injection molding is performed on a hydraulic press with clamp force from 500 kN to 1200 kN depending on projected area; hold pressure is maintained until gate freeze, typically 8 s to 15 s for handle wall thicknesses of 3 mm to 6 mm. Terminal products include forceps bodies, retractor handles, and torque-limited screwdriver grips.

Field failure modes observed on injection molding lines for PA12 surgical instruments include gate blush when injection speed exceeds 150 mm/s, and sink marks over thick bosses if hold pressure is released before gate freeze. These defects are controlled by profiling hold pressure in three stages and by using a mold temperature of 70 °C to 80 °C to promote uniform crystallization. The resin is purged after each run with a low-melt-viscosity PA12 purge compound to prevent black specks in subsequent translucent components.

When Gamma Irradiation Dictates Material Selection for Single-Use Diagnostic Manifolds

Microfluidic manifolds, valve blocks, and fluidic path connectors for single-use diagnostic systems are injection-molded from VESTAMID Care ML17 in an ISO Class 8 cleanroom per ISO 14644-1:2015. The resin is pre-dried to 0.10 % residual moisture, then melt processed at 225 °C with a mold temperature of 65 °C. The aliphatic polyamide 12 backbone tolerates gamma irradiation doses from 25 kGy to 50 kGy with a measurable but non-catastrophic reduction in elongation at break, as evaluated under ISO 11137-1:2006 and ISO 11137-2:2013 sterilization validation protocols. If white or colored manifold components are required, 1 wt% to 3 wt% of a masterbatch is added, provided the masterbatch passes ISO 10993-5:2009 and ISO 10993-10:2010. A negative-venting vacuum system and a cold runner with valve gates are used to avoid splay and gas entrapment in flat manifold sections with wall thickness 1.0 mm to 2.0 mm. Dimensional stability after irradiation is supported by the low moisture uptake of PA12, which limits post-sterilization swelling in humid storage. Terminal products include microtiter plate manifolds, pneumatic valve housings, and luer-actuated distribution blocks.

If bioburden recovery indicates a validation dose below 15 kGy, gamma irradiation may still be used but the effect on the PA12 alkyl chain should be verified by tensile impact testing per ISO 8256:2023 and by solution viscosity measurement in m-cresol at 25 °C. The latter detects chain scission before a decline in bulk mechanical properties is visible in molded manifold bodies. Process control via a negative-venting vacuum system is critical to reduce oxygen exposure during melting; oxygen-assisted degradation at melt temperatures above 240 °C can produce brown streaks and surface silica-like deposits.

Application scenario	Standard or test method	Endpoint / criterion
Intravascular catheter shaft	ISO 10993-1:2018; ISO 10993-4:2017; ISO 10993-5:2009; ISO 10993-10:2010	Surface contact, limited duration; hemolysis, complement activation
Luer connectors	ISO 80369-7:2016; ISO 80369-20:2015	Taper dimensional conformity; leakage at 1250 mm Hg
Surgical instruments	ISO 17665-1:2006; ISO 10993-1:2018	Steam sterilization validation; biocompatibility
Diagnostic manifolds	ISO 11137-1:2006; ISO 11137-2:2013	Radiation sterilization dose; bioburden monitoring
Inhaler components	ISO 10993-13:2010; ISO 10993-18:2020	Extractables; chemical characterization
Multi-lumen tubing	ISO 10993-1:2018; ISO 10993-4:2017	Blood contact if intended; hemolysis

Nebulizer and Inhaler Component Stability Against Lipid-Based Drug Formulations

Dose counter gears, actuator bodies, and mouthpiece adapters in dry powder and metered-dose inhaler systems are molded from VESTAMID Care ML17; the resin is selected for its resistance to lipid-based excipients and low extractables in ethanol-water mixtures. The material is pre-dried at 80 °C to 0.08 % residual moisture. Molding is performed with a melt temperature of 235 °C and a mold temperature of 70 °C. Gear components with module 0.5 mm and tooth counts from 18 to 40 are produced using a hot runner system with valve gates; cycle time ranges from 12 s to 22 s. Chemical resistance is evaluated by immersion in 70 % ethanol and in a representative lipid emulsion at 40 °C for 24 h, with extractable and leachable characterization performed according to ISO 10993-13:2010 and ISO 10993-18:2020. Extractables testing must demonstrate total organic carbon below device-specific acceptance limits; published data for this specific formulation and ML17 in inhaler applications is limited and should be established for each drug product. Terminal products are internal dose counter mechanisms, actuator bodies, and mouthpiece adapters.

Multi-Lumen Tubing Requires Tooling Compensation for PA12 Shrinkage

Multi-lumen tubing used for drug infusion and fluid management is extruded from VESTAMID Care ML17 on a single-screw extruder with a 19 mm screw, L/D 24:1, a barrier mixing section, and a gear pump. The melt temperature at the die is set between 220 °C and 240 °C; melt pressure before the screen pack is maintained at 150 bar to 250 bar. Multi-lumen tip and die tooling is designed with a draw-down ratio of 2:1 to 4:1 and a draw balance controlled by individual lumen air pressure. Wall thickness distribution is verified by optical microscopy on cross-sections every 500 m. This material can be drawn to lumen diameters as small as 0.3 mm in clinical tubing, with ovality controlled within 0.05 mm. No plasticizer addition is required; additive levels, when required for slip or color, are maintained below 0.5 wt% and must be supported by ISO 10993-5:2009 data. Compliance for fluid contact is established under ISO 10993-1:2018 with additional hemocompatibility testing per ISO 10993-4:2017 where blood contact is intended. Terminal product is a multi-lumen catheter body for infusion or drain applications.

Screen pack configuration is 200/400/600 µm layered stainless steel mesh to generate back pressure and homogenize the melt without excessive shear heating. The gear pump inlet pressure is maintained below 80 bar to avoid cavitation; the die head pressure after the pump is regulated to 150 bar to 250 bar. Long sizing die immersion lengths of 300 mm to 600 mm in water at 20 °C to 40 °C control ovality. The terminal product must pass peristaltic pump wear testing for a minimum of 1 000 000 cycles at 60 rpm, but published data for ML17 under peristaltic pump abrasion is limited and should be generated for each tubing geometry.

Wearable drug delivery pump housings and continuous glucose monitor frames are molded from VESTAMID Care ML17 in an ISO Class 8 cleanroom per ISO 14644-1:2015 to manage dimensional stability under cyclic thermal and humidity conditions. The resin is pre-dried to 0.10 % residual moisture, then injection molded at 230 °C to 250 °C with a mold temperature of 65 °C to 80 °C. Housings with wall thicknesses from 1.2 mm to 2.5 mm are produced on a hot-runner mold with valve-gated drops; total cycle time is 20 s to 30 s. Because PA12 has lower equilibrium water absorption than PA6 or PA66, dimensional change during storage at 65 % relative humidity and 25 °C is reduced, but snap-fit features should be validated for insertion force after 48 h humidity conditioning per ISO 291:2008. The material is suitable for housing parts that contact the patient only transiently or indirectly; biocompatibility is documented under ISO 10993-1:2018, with ISO 10993-5:2009 and ISO 10993-10:2010 testing applied to representative devices. Terminal products are pump outer housings, reservoir retainer clips, and sensor mounting frames.